North China Pharmaceutical Company.Ltd (SHA:600812)

China flag China · Delayed Price · Currency is CNY
6.87
+0.01 (0.15%)
Jul 25, 2025, 10:44 AM CST
0.15%
Market Cap11.77B
Revenue (ttm)9.89B
Net Income (ttm)166.33M
Shares Out1.72B
EPS (ttm)0.10
PE Ratio71.20
Forward PE62.36
Dividend0.03 (0.44%)
Ex-Dividend DateJul 25, 2025
Volume14,168,458
Average Volume25,531,764
Open6.85
Previous Close6.86
Day's Range6.80 - 7.01
52-Week Range4.35 - 7.13
Beta0.63
RSI65.05
Earnings DateAug 14, 2025

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China. The company primarily offers anti-infective drugs; biotechnology drugs; cardiovascular cerebrovascular; immunomodulators; and vitamins and health products. It also provides chemical pharmaceuticals, biological agricultural and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is based in Shijiazhuang, China. [Read more]

Sector Healthcare
Founded 1992
Employees 10,088
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600812
Full Company Profile

Financial Performance

In 2024, SHA:600812's revenue was 9.87 billion, a decrease of -2.48% compared to the previous year's 10.12 billion. Earnings were 126.99 million, an increase of 2496.79%.

Financial Statements

News

There is no news available yet.